Cleveland BioLabs (CBLI): Today's Weak On High Volume Stock

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Cleveland BioLabs ( CBLI) as a weak on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Cleveland BioLabs as such a stock due to the following factors:

  • CBLI has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $2.9 million.
  • CBLI has traded 63,184 shares today.
  • CBLI is trading at 2.17 times the normal volume for the stock at this time of day.
  • CBLI is trading at a new low 8.20% below yesterday's close.

'Weak on High Relative Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as material stock news, analyst downgrades, insider selling, selling from 'superinvestors,' or that hedge funds and traders are piling out of a stock ahead of a catalyst. Regardless of the impetus behind the price and volume action, when a stock moves with strength and volume it can indicate the start of a new trend on which early investors can capitalize (or avoid losses by trimming weak positions). In the event of a well-timed trading opportunity, combining technical indicators with fundamental trends and a disciplined trading methodology should help you take the first steps towards investment success.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in CBLI with the Ticky from Trade-Ideas. See the FREE profile for CBLI NOW at Trade-Ideas

If you liked this article you might like

3 Breakout Stocks Under $10 Set to Soar

3 Stocks Under $10 to Trade for Big Breakouts

3 Stocks Under $10 Triggering Breakout Trades

Cleveland BioLabs (CBLI) Stock Spikes on $25 Million Equity Financing Agreement